Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bobby Gaspar

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Trends in Molecular Medicine|March 20, 2016
Treating Immunodeficiency through HSC Gene TherapyClaire Booth, H Bobby Gaspar, Adrian J Thrasher
British Journal of Haematology|June 6, 2015
Gene therapy for monogenic disorders of the bone marrowSujal Ghosh, Adrian J Thrasher, H Bobby Gaspar
Current Gene Therapy|February 22, 2012
Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby Gaspar
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby Gaspar
Human Gene Therapy|June 14, 2012
Gene therapy for primary immunodeficienciesChristine Rivat, Giorgia Santilli, H Bobby Gaspar, et al.
Annals of Human Genetics|December 22, 2006
Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestryJuan J Sanchez, Gemma Monaghan, Claus Børsting, et al.
Blood|July 30, 2009
How I treat ADA deficiencyH Bobby Gaspar, Alessandro Aiuti, Fulvio Porta, et al.
Blood|October 12, 2013
How I treat severe combined immunodeficiencyH Bobby Gaspar, Waseem Qasim, E Graham Davies, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transductionWaseem Qasim, Taylor Mackey, Jo Sinclair, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous miceChiara Bacchelli, Karen F Buckland, Sylvie Buckridge, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Trends in Molecular Medicine|March 20, 2016
Treating Immunodeficiency through HSC Gene TherapyClaire Booth, H Bobby Gaspar, Adrian J Thrasher
British Journal of Haematology|June 6, 2015
Gene therapy for monogenic disorders of the bone marrowSujal Ghosh, Adrian J Thrasher, H Bobby Gaspar
Current Gene Therapy|February 22, 2012
Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby Gaspar
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby Gaspar
Human Gene Therapy|June 14, 2012
Gene therapy for primary immunodeficienciesChristine Rivat, Giorgia Santilli, H Bobby Gaspar, et al.
Annals of Human Genetics|December 22, 2006
Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestryJuan J Sanchez, Gemma Monaghan, Claus Børsting, et al.
Blood|July 30, 2009
How I treat ADA deficiencyH Bobby Gaspar, Alessandro Aiuti, Fulvio Porta, et al.
Blood|October 12, 2013
How I treat severe combined immunodeficiencyH Bobby Gaspar, Waseem Qasim, E Graham Davies, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transductionWaseem Qasim, Taylor Mackey, Jo Sinclair, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2011
The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous miceChiara Bacchelli, Karen F Buckland, Sylvie Buckridge, et al.
Pageof 12